H. Awata et al., STRUCTURAL ORGANIZATION AND ANALYSIS OF THE HUMAN FUMARYLACETOACETATEHYDROLASE GENE IN TYROSINEMIA TYPE-I, Biochimica et biophysica acta. Molecular basis of disease, 1226(2), 1994, pp. 168-172
Fumarylacetoacetate hydrolase (FAH) is a metabolic enzyme functioning
at the last step of tyrosine catabolism. Deficiency in this enzyme act
ivity is associated with tyrosinemia type I, characterized by hypertyr
osinemia, liver dysfunction, renal tubular dysfunction, liver cirrhosi
s, and hepatic tumors. We isolated from a human gene library a chromos
omal gene related to FAH. The human FAH gene is 30 kilobases long and
is split into 14 exons. All of the splice donor and acceptor sites con
form to the GT/AG rule. We also analyzed findings in a patient with ty
rosinemia type I with respect to the mutation responsible for defects
in the enzyme. A nucleotide change from T to G was found in the exon 2
of the gene and this change was accompanied by an amino acid substitu
tion (Phe62Cys). Transfection and expression analysis of the cDNA in c
ultured BMT-10 cells with the nucleotide substitution demonstrated tha
t the substitution was indeed responsible for the decreased activity o
f the enzyme in the patient. These results confirmed that the T to G m
utation was one of the causes of tyrosinemia type I. Structure of the
FAH gene and tests for expression of the mutant FAH will facilitate fu
rther understanding of various aspects of FAH.